Drug Development
Listings
-
L929/A
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resis...
-
Mouse Hepatocytes
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Our mouse hepatocytes are prepared using the same careful isolation and cryopreservation techniques as our human lots. Characterization methods of cryopreserved hepatocytes include ECOD, 7-HCG and 7-HCS for phase I and phase II enzyme activities. We ...
-
MC-38
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-6983J Description Established from C57BL/6 mouse colon adenocarcinoma Species Mus musculus (Mouse) Source Intestine; Colon Recommended Medium 90% RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/mc-38-csc-6983j-item-45531.htm
-
CT-26
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9367L Description Species Mus musculus (Mouse) Source Intestine; Colon Recommended Medium 90% RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/CT-26-CSC-C9367L-item-39544.htm
-
FL83B
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$FL83B is a spontaneously immortalized hepatocyte cell line derived from the liver of a 15 to 17-day-old fetal C57BL/6J mouse. https://www.creative-bioarray.com/fl83b-csc-c7104j-item-49147.htm
-
NH-6
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C6326J Description Human cell line derived from neuroblastoma of adrenal gland. Species Homo sapiens (Human) Source Adrenal Gland https://www.creative-bioarray.com/nh-6-item-csc-c6326j-42926.htm
-
BALB/3T3 clone A31
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Species: mouse - embryo, 14 to 17 days old, Mus musculus Strain: BALB/c Virus Susceptibility: Herpes simples; vesicular stomatitis (Indiana) Tumorigenecity: no https://www.creative-bioarray.com/BALB-3T3-clone-A31-CSC-C9339L-item-39487.htm
-
Py230
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$The Py230 cell line is an epithelial-like murine mammary luminal tumor cell line that has properties similar to those of normal mouse mammary stem cells. It was derived from a mammary adenocarcinoma that spontaneously arose in a MMTV-PyMY (mouse mamm...
-
Py8119
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$The P8119 cell line represents a mesenchymal tumor cell derived from a mammary adenocarcinoma that spontaneously arose in a MMTV-PyMY (mouse mammary tumor virus promoter driven Polyoma middle T-antigen) transgenic C57BL/6 female mouse. This cell line...
-
NMuMG
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Initiated from the mammary gland tissue of an adult NAMRU mouse and one of a series of epithelial cell lines derived from normal glandular tissue of mice. The cells exhibit many ultrastructural features of secretory epithelium as well as desmosomes o...
-
MS-5
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Established by irradiation of the adherent cells in long-term bone marrow cultures derived from C3H/HeNSlc strain mice https://www.creative-bioarray.com/MS-5-CSC-C2763-item-1619.htm
-
NS20Y
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Established from a A/J mouse strain with neuroblastoma C1300; cells were described to be aneuploid and to contain high specific activity of choline acetyltransferase https://www.creative-bioarray.com/NS20Y-CSC-C1062-item-1530.htm







